Related Experiment Video
Updated: Nov 29, 2025

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
Published on: May 15, 2019
Calcineurin inhibitors: a double-edged sword
Adaku C Ume1, Tara-Yesomi Wenegieme1, Clintoria R Williams1
1Department of Neuroscience Cell Biology and Physiology, Boonshoft School of Medicine, College of Science and Mathematics, Wright State University, Dayton, Ohio.
Calcineurin inhibitor-induced renal fibrosis involves calcineurin alpha (CnAα) and calcineurin beta (CnAβ) isoforms. Loss of CnAα activity contributes to kidney damage, necessitating further research into its specific mechanisms.
Area of Science:
- Nephrology
- Immunology
- Molecular Biology
Background:
- Calcineurin inhibitors (CNIs) are crucial immunosuppressants but can cause renal fibrosis.
- Two calcineurin isoforms, CnAα and CnAβ, have distinct roles in kidney function and immune response.
- CnAα is vital for kidney development, while CnAβ regulates immune responses and NFAT signaling.
Purpose of the Study:
- To review current research on CnA isoform-specific mechanisms in CNI-induced renal fibrosis.
- To elucidate how CnAα deficiency leads to progressive renal damage.
- To identify downstream mediators of CnAα signaling involved in profibrotic protein upregulation.
Main Methods:
- Literature review of studies investigating calcineurin isoforms and renal fibrosis.
- Analysis of research on CNI effects on CnAα and CnAβ activity.
- Examination of signaling pathways involved in CNI-induced nephrotoxicity.
Main Results:
- Loss of CnAα activity is linked to increased profibrotic protein expression in the kidney.
- CnAβ primarily influences immune response and glomerular signaling via NFAT.
- Distinct roles of CnAα and CnAβ in renal fibrosis are emerging.
Conclusions:
- Understanding CnA isoform-specific functions is critical for addressing CNI-induced renal fibrosis.
- Further research is needed to clarify CnAα's role in progressive renal damage.
- Targeting CnA isoform-specific pathways may lead to safer CNIs with reduced nephrotoxicity.
More Related Videos
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
08:38Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
Published on: November 8, 2015
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Synthesis and Functions of Calcitonin
The exact mechanisms by which calcitonin operates in calcium homeostasis remain elusive, but its significance is evident in several vital...
Inhibition of Cdk Activity
Acute Kidney Injury IV: Diagnostic Studies and Prevention